Fig. 5

Construction of the SRGs-related prognostic signature and the validation nomogram. A Relationships between the SiaTs_Cluster, gene_Cluster, risk group and the survival outcomes visualized by Sankey diagram. B Comparison of the risk score between SiaTs_Cluster A (blue) and B groups (yellow). C Comparison of the risk score between gene_Cluster A (blue) and B groups (yellow). D LASSO analysis on the seven candidate SRGs. E Cross-validation in the LASSO regression. F Kaplan–Meier curve for overall survival between high- (red) and low-risk groups (blue). G Time-dependent receiver operating characteristic curve analysis of the prognostic model in predicting 1-, 3-, and 5-years survival rates of bladder cancer patients. H The distribution of the risk score and the patient survival outcome plots. I Heatmap of the 7 signature genes’ expression in the prognostic model. J Nomogram constructed based on the risk score and clinical characterization to predict the overall survival of bladder cancer patients. K Calibration plot for the internal validation of the nomogram. *P < 0.05, **P < 0.01. ***P < 0.001